Virtual Reality for Panic Disorder With Agoraphobia: a Clinical Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 4
- 主要终点
- Mobility Inventory
研究概览
简要总结
Panic disorder with agoraphobia (PDA) is associated with considerable personal distress, functional disability and societal costs. A large number of studies have shown that Cognitive Behavior Therapy (CBT) is a highly effective treatment for PDA. However, the CBT-protocols proven to be most effective involves repeated exposure to the particular environments the agoraphobic patient fears such as trains, tunnels, lifts and shops. This cause great practical problems for health care services as such therapeutic efforts involves spending considerable time outside the clinic. For primary care services this is particularly challenging due to the large number of patients expected to be seen. Normally clinicians meet up to 7 patients daily which makes it almost practically impossible to offer 2-hour sessions, which is necessary to carry out the relevant exposure tasks. Hence, the treatment proven to be most effective, which primary care services are commissioned to deliver, is too comprehensive and time consuming to be applied in real practice.
The investigators believe that a possible solution to the above problem is to provide evidence-based CBT but with the exposure components carried out through Virtual Reality (VR) rather than in vivo. Some research has already been done with virtual reality and exposure therapy for anxiety disorders with promising results. The aim of this pilot study is to treat patients with agoraphobia with or with a history of panic disorder with a standardized exposure-based CBT-protocol through VR. The virtual environments that are used for the study are live sequences filmed in 360°. The investigators hypothesize that CBT with VR will be effective and lead to improvements on measures of panic disorder and agoraphobia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Mobility Inventory
时间窗: Baseline, post-treatment (10 weeks), 6-month follow-up, 12-month follow-up
Change at post-treatment (10 weeks), 6-month follow-up, and 12 month follow-up compared to baseline
次要结局
- Patient Health Questionnaire(Baseline, post-treatment (10 weeks), 6-month follow-up, 12-month follow-up)
- The World Health Organisation Quality of Life(Baseline, post-treatment (10 weeks), 6-month follow-up, 12-month follow-up)
- Panic disorder severity scale(Baseline, post-treatment (10 weeks), 6-month follow-up, 12-month follow-up)
- World Health Organisation Disability Assessment Schedule(Baseline, post-treatment (10 weeks), 6-month follow-up, 12-month follow-up)
研究者
Erik Hedman
Principal investigator, PhD
Karolinska Institutet
